Company news
Expres2ion Biotech Holding Ab (OMXSTO:EXPRS2) news
Every Expres2ion Biotech Holding Ab press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
ExpreS2ion resolves on a set-off issue to one guarantor in connection with completed rights issue
May 11, 2026
ExpreS2ion Biotech: Rights issue outcome – SEK31.8m raised
May 5, 2026
ExpreS2ion announces final outcome of its rights issue of units
May 4, 2026
ExpreS2ion Biotech advances breast cancer project with rights issue of SEK 53 million
April 20, 2026
ExpreS2ion featured in BioStock investor presentation as subscription period opens in SEK 53 million rights issue
April 16, 2026
ExpreS2ion publishes prospectus in connection with SEK 53 million rights issue to complete Phase I and support partnering activities
April 14, 2026
The Board of Directors of ExpreS2ion has resolved on a rights issue of units of approximately SEK 53 million, primarily to advance its le...
April 7, 2026
ExpreS2ion Announces Financial Results for the Full-Year and Fourth Quarter of 2025
February 19, 2026